- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in dr reddys
Dr Reddy's Q3 Net Profit Rises Multi-fold To Rs 707 Cr
Revenues stood at Rs 5,319.7 crore during the third quarter as compared with Rs 4,929.6 crore in the same period of 2020-21, Dr Reddy's Laboratories said.
Read More
DRDO Develops Survival Kit For Troops Deployed At Minus 50 Degrees Celcius
Import substitution technology for extreme cold weather gear handed over to 5 Indian companies
Read More
Mansukh Mandaviya Holds Meeting With Dr Reddy's Lab Chairman On Sputnik V Production, Supply
The Hyderabad-based drug major has already stated that the locally manufactured Sputnik V will be available from September-October period.
Read More
Sputnik V Soft Launched In Over 50 Cities In India: Dr Reddys
The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Read More
Dr Reddy's Bullish On OTC Products Sale Through Amazon, Others In US
Dr Reddys had three late projects at different levels of development, ranging from products that have completed Phase 2 clinical trials to a product that is undergoing pivotal studies for registration.
Read More
Dr Reddy's Expects Biz Growth To Be Volatile In Current Fiscal
Higher productivity is also enabled by scaling up of robotic process automation (RPAs) as well as digitalised processes with automated incident tracking and near zero manual errors
Read More
Dr Reddy's Lines Up Rs 1,000 Cr Capex For Current Fiscal
The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications and capability ramp-up in marketing and digitalisation
Read More
Dr Reddy's In Talks With RDIF On Sputnik V For Other Countries
RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September
Read More
Dr Reddy's Q4 Profit Dips 29 Pc To Rs 557 Cr
Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20
Read More
Dr Reddy's Inks Licensing Pact With Eli Lilly For COVID-19 Treatment Drug
The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.
Read More
Dr Reddy's Launches Generic Drug In US Market
The Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.
Read More
Lindstrom To Launch Its First Clean Room Service In Pune In March 2018
Lindstrom India, a subsidiary of Lindstrom Group, a Finnish workwear service company which has completed 170 years of its existence, is the only organized rental workwear services company in India. Juha Laurio, President & CEO, Lindstrom, Finland & Anupam Chakrabarty, Managing Director, Lindstrom, India, speak to BW Businessworld on the launch of their first clean room service in Pune in March 2018, the new opportunities in healthcare, food sector and how does Lindstrom support sustainability
Read More
Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge
The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.
Read More
Dr Reddy's Says German Regulator Makes Six Observations On Unit
Dr. Reddy's, in an exchange filing, did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports
Read More
India Eyes Oil-For-Drugs Deal With Venezuela To Recoup Pharma Cash
Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies
Read More